Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT00899158
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Meets 1 of the following criteria:
* Diagnosis or suspicion of pancreatic cancer
* Any stage disease allowed
* At least 5% weight loss within the past 6 months
* Scheduled to undergo exploratory surgery
* Scheduled to undergo exploratory surgery for suspected nonmalignant condition
* No weight loss OR weight loss due to specific reason (e.g., bowel obstruction, infection, or nausea/vomiting)
* No cancer diagnosis other than primary pancreatic carcinoma
PATIENT CHARACTERISTICS:
* ECOG performance status 0-3
* Life expectancy ≥ 12 weeks
* No pacemakers or implanted defibrillators
PRIOR CONCURRENT THERAPY:
* Prior or concurrent chemotherapy and radiotherapy allowed
* Prior or concurrent biological therapy and surgery allowed
* At least 4 weeks since prior corticosteroids or anabolic steroids
* Other concurrent anticancer therapy allowed
* No concurrent corticosteroids or anabolic steroids, thalidomide, eicosapentaenoic acid (EPA), or Juven for weight loss
* Concurrent steroids (i.e., antiemetics) associated with chemotherapy allowed
* No concurrent nutritional supplements with EPA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00899158
Study Brief:
Protocol Section:
NCT00899158